相关实验视频

Updated: Jun 13, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

在MECP2重复综合征中模拟反感性寡核酸治疗人类iPSC衍生的神经元揭示了对MeCP2水平有反应的基因表达程序

Sameer S Bajikar^1,2,3,4, Yehezkel Sztainberg^1,2, Alexander J Trostle^2,5

¹Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, United States.

Human molecular genetics

|September 15, 2024

概括

针对MECP2的反意义寡核化物显示出对治疗MECP2重复综合征 (MDS) 的前途. 这种方法部分挽救了神经元异常形态,并识别了人类神经元中关键基因表达变化,提供了新的治疗策略.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

基因组拷贝数变异 (CNVs) 使理解神经发育障碍变得复杂.
MECP2重复综合征 (MDS) 涉及Xq28的重复,包括MECP2和其他基因.
之前在小鼠模型上的研究表明,将MECP2剂量正常化可以拯救表型.

研究的目的:

评估针对MECP2的人类神经元的反感性寡核酸 (ASO) 的治疗潜力,这些神经元来自MDS患者.
在MDS神经元中识别由ASO治疗调节的基因表达特征.
建立一个范式来评估在CNV和治疗点中的基因贡献.

主要方法:

从患有MDS的患者衍生诱导多能干细胞 (iPSC) 生成的人类神经元.
被治疗的MDS人类神经元具有针对MECP2.2的ASO.
分析了基因表达特征和神经元形态.
与雷特综合征和MeCP2贫乏神经元模型进行了比较.

主要成果:

在MDS神经元中,ASO治疗部分挽救了神经元形态异常.
确定了一种对MeCP2水平敏感的基因表达特征,并通过ASO治疗进行调制.
揭示了对人类神经元中MeCP2水平有质感的基因表达程序.
证明了针对MECP2的ASO有益于人类MDS神经元.

结论:

针对MECP2的ASO为人类MDS神经元提供了潜在的治疗益处.
该研究为评估CNV中的个体基因贡献及其治疗潜力的研究提供了一个框架.
这项研究强调了MECP2剂量在神经发育障碍中的重要性.

关键词:

副本数量的增加遗传综合征遗传综合征遗传综合征基因组疾病基因组疾病 iPSC 衍生神经元的神经元.翻译学翻译学翻译学翻译学

更多相关视频

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Published on: May 1, 2019

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.